Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2002 1
2003 1
2017 1
2018 3
2019 1
2020 3
2021 2
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM; TRAILBLAZER-ALZ 2 Investigators. Sims JR, et al. JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239. JAMA. 2023. PMID: 37459141 Free PMC article.
Chemical Specification of E3 Ubiquitin Ligase Engagement by Cysteine-Reactive Chemistry.
Sarott RC, You I, Li YD, Toenjes ST, Donovan KA, Seo P, Ordonez M, Byun WS, Hassan MM, Wachter F, Chouchani ET, Słabicki M, Fischer ES, Ebert BL, Hinshaw SM, Gray NS. Sarott RC, et al. Among authors: toenjes st. J Am Chem Soc. 2023 Oct 11;145(40):21937-21944. doi: 10.1021/jacs.3c06622. Epub 2023 Sep 28. J Am Chem Soc. 2023. PMID: 37767920
Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader.
Teng M, Jiang J, Wang ES, Geng Q, Toenjes ST, Donovan KA, Mageed N, Yue H, Nowak RP, Wang J, Manz TD, Fischer ES, Cantley LC, Gray NS. Teng M, et al. Among authors: toenjes st. Angew Chem Int Ed Engl. 2023 Apr 24;62(18):e202302364. doi: 10.1002/anie.202302364. Epub 2023 Mar 27. Angew Chem Int Ed Engl. 2023. PMID: 36898968 Free PMC article.
Development and Utility of a PAK1-Selective Degrader.
Chow HY, Karchugina S, Groendyke BJ, Toenjes S, Hatcher J, Donovan KA, Fischer ES, Abalakov G, Faezov B, Dunbrack R, Gray NS, Chernoff J. Chow HY, et al. Among authors: toenjes s. J Med Chem. 2022 Dec 8;65(23):15627-15641. doi: 10.1021/acs.jmedchem.2c00756. Epub 2022 Nov 23. J Med Chem. 2022. PMID: 36416208 Free PMC article.
Catalytic Atroposelective Synthesis of N-Aryl Quinoid Compounds.
Vaidya SD, Toenjes ST, Yamamoto N, Maddox SM, Gustafson JL. Vaidya SD, et al. Among authors: toenjes st. J Am Chem Soc. 2020 Feb 5;142(5):2198-2203. doi: 10.1021/jacs.9b12994. Epub 2020 Jan 28. J Am Chem Soc. 2020. PMID: 31944689 Free PMC article.
Updated resources for "Talking About Medications" workshop.
Toenjes S, Deng A. Toenjes S, et al. Can Pharm J (Ott). 2022 Feb 24;155(2):78. doi: 10.1177/17151635221079619. eCollection 2022 Mar-Apr. Can Pharm J (Ott). 2022. PMID: 35300018 Free PMC article. No abstract available.
20 results